MAUREL ET PROM (MAU.PA)       3.425  +0.11 (+3.32%)

3.425  +0.11 (+3.32%)

FR0000051070 - Common Stock


Fundamental Rating

6

Overall MAU gets a fundamental rating of 6 out of 10. We evaluated MAU against 43 industry peers in the Oil, Gas & Consumable Fuels industry. MAU has a great profitability rating, but doesn't score so well on its financial health evaluation. MAU is evaluated to be cheap and growing strongly. This does not happen too often!




Profitability

Profitability Rating

7

MAU's Return On Assets of 12.75% is amongst the best of the industry. MAU does better than the industry average Return On Assets of 8.17%.
MAU's Return On Equity of 28.53% is amongst the best of the industry. MAU does better than the industry average Return On Equity of 20.45%.

MAU's Profit Margin of 33.75% is amongst the best returns of the industry. MAU outperforms 90% of its industry peers. The industry average Profit Margin is 15.08%.
The Piotroski-F score of MAU is 7.00. This is a strong score and indicates good health and profitability for MAU.
VS Industry

ROA (12.75%) VS Industry: 78% outperformed.

1.67
39.62

ROE (28.53%) VS Industry: 71% outperformed.

2.48
93.55

Profit Margin (33.75%) VS Industry: 90% outperformed.

2.83
62.40

Valuation

Valuation Rating

9

The Price/Earnings Ratio is 3.23, which indicates a rather cheap valuation of MAU.
Compared to an average industry Price/Earning Ratio of 5.69, MAU is valued rather cheaply. On top of this MAU is cheaper than 82% of the companies listed in the same industry.
The Forward Price/Earnings Ratio of 3.72 indicates a rather cheap valuation of MAU.
MAU's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

When comparing the current price to the book value of MAU, it is valued rather cheaply. It is trading at 0.92 times its book value.
Compared to an average industry price book ratio of 1.35, MAU is valued rather cheaply
When comparing the Enterprise Value to EBITDA ratio of MAU to the average industry ratio of 3.16, MAU is valued rather cheaply.
VS Industry

Price/Earnings (3.23) VS Industry: 82% outperformed.

31.13
0.49

Price/Book (0.92) VS Industry: 71% outperformed.

116.44
0.04

Enterprise Value/ EBITDA (2.14) VS Industry: 62% outperformed.

16.45
0.52

Growth

Growth Rating

7

The Earnings Per Share has grown by an impressive 606.84% over the past year.
Measured over the past 5 years, MAU shows a very strong growth in Earnings Per Share. The EPS has been growing by 26.08% on average per year.
Based on estimates for the next 5 years, MAU will show a very strong growth in Earnings Per Share. The EPS will grow by 22.92% on average per year.
The Revenue has grown by 77.58% in the past year. This is a very strong growth!

When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is stable.
Measured over the past 5 years, MAU shows a small growth in Revenue. The Revenue has been growing by 9.59% on average per year.
Based on estimates for the next 5 years, MAU will show a small growth in Revenue. The Revenue will grow by 8.77% on average per year.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is stable.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A 26.08% 606.84% 103.66% 46.54% 22.92% N/A
Revenue9.59% 4.32% 77.58% 45.26% 16.06% 8.77% N/A

Health

Health Rating

2

The Debt to Equity ratio of MAU is way better than the industry averages.
MAU has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for MAU.
MAU has a Current Ratio of 0.71. This is a bad value and indicates that MAU is not financially healthy enough and could expect problems in meeting its short term obligations.
Compared to an average industry Current Ratio of 1.63, MAU is worse placed to pay its short term obligations than its industry peers. 95% of its industry peers have a better Current Ratio.

A Quick Ratio of 0.69 indicates that MAU may have some problems paying its short term obligations.
When comparing the Quick Ratio of MAU to the average industry Current Ratio of 1.46, MAU is less able to pay its short term obligations than its industry peers. 90% of its industry peers have a better Quick Ratio.
Based on the Altman-Z score of 1.72, we must say that MAU is in the distress zone and has some risk of bankruptcy.
When comparing the Altman-Z score of MAU to the average industry Altman-Z score of 2.03, MAU is less financially healthy than its industry peers.
VS Industry

Debt/Equity (0.11) VS Industry: 76% outperformed.

12.09
0.00

Quick Ratio (0.69) VS Industry: 10% outperformed.

0.23
14.91

Current Ratio (0.71) VS Industry: 5% outperformed.

0.45
14.91

Altman-Z (1.72) VS Industry: 40% outperformed.

-4.67
12.77

Dividend

Dividend Rating

6

MAU has a Yearly Dividend Yield of 4.24%, which is a nice return.
MAU's Dividend Yield is rather good when compared to the S&P500 average which is at 2.55.
The dividend of MAU is nicely growing with an annual growth rate of 51.38%!

MAU's Dividend Yield is slightly below the industry average, which is at 6.74.
MAU's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
VS Industry

Dividend Yield (4.24%) VS Industry: 25% outperformed.

0.36
96.88

MAUREL ET PROM3.425

EPA:MAU (3/21/2023, 12:31:33 PM)+0.11 (+3.32%)

Chartmill FA Rating
GICS Sector Energy
GICS IndustryGroup Energy
GICS Industry Oil, Gas & Consumable Fuels
Earnings (Last) N/A N/A Earnings (Next) N/A N/A
Inst Owners N/A Inst Owner Change N/A
Ins Owners N/A Ins Owner Change N/A
Market Cap 676.84M Analysts 77.14
Price Target 4.35 (27.01%)

Dividend
Industry RankSector Rank
Dividend Yield 4.24%
Dividend Growth(5Y) 51.38% DP N/A
Div Incr Years N/A Div Non Decr Years N/A
Ex-Date N/A

Surprises & Revisions
EPS beat(2) N/A Avg EPS beat(2) N/A
Min EPS beat(2) N/A Max EPS beat(2) N/A
EPS beat(4) N/A Avg EPS beat(4) N/A
Min EPS beat(4) N/A Max EPS beat(4) N/A
Revenue beat(2) N/A Avg Revenue beat(2) N/A
Min Revenue beat(2) N/A Max Revenue beat(2) N/A
Revenue beat(4) N/A Avg Revenue beat(4) N/A
Min Revenue beat(4) N/A Max Revenue beat(4) N/A
PT rev (1m) 0.39% PT rev (3m) 0.39%
EPS NQ rev (1m) N/A EPS NQ rev (3m) N/A
EPS NY rev (1m) 0% EPS NY rev (3m) 0%
Revenue NQ rev (1m) N/A Revenue NQ rev (3m) N/A
Revenue NY rev (1m) -1.69% Revenue NY rev (3m) -1.69%

Valuation
Industry RankSector Rank
PE 3.23
Fwd PE 3.72
P/S 1.09
P/FCF 3.11
P/OCF 1.72
P/B 0.92
P/tB 1.22
EV/EBITDA 2.14
EPS(TTM) 1.06 EY 30.95%
EPS(NY) 0.92 Fwd EY 26.88%
FCF(TTM) 1.1 FCFY 32.11%
OCF(TTM) 1.99 OCFY 58.18%
SpS 3.15 BVpS 3.72
TBVpS 2.81 PEG (NY) 0.03
PEG (5Y) N/A

Profitability
Industry RankSector Rank
ROA 12.75%
ROE 28.53%
ROIC 18.92%
ROICexc 24.61%
ROICexgc 31.67%
OM 46.39%
PM 33.75%
GM 83.77%
ROICexgc(3y) N/A ROICexcg growth 3Y 35.22%
ROICexcg growth 5Y 74.37% ROICexc(3y) N/A
ROICexc growth 3Y 30.84% ROICexc growth 5Y 71.01%
OM growth 3Y 3.13% OM growth 5Y 42.28%
PM growth 3Y 22.01% PM growth 5Y N/A
GM growth 3Y 1.51% GM growth 5Y 3.38%
F-Score 7 Asset Turnover 0.38

Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 1.96
Debt/EBITDA 1.1
Cap/Depr 183.07%
Profit Quality 103.49%
Current Ratio 0.71
Quick Ratio 0.69
Altman-Z 1.72
F-Score 7 WACC 7.04%
ROIC/WACC 4.5 Cap/Depr(3y) 91.22%
Cap/Depr(5y) 86.83% Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y 606.84% EPS 3Y 26.08%
EPS 5Y N/A EPS growth Q2Q 330.12%
EPS Next Y 103.66% EPS Next 2Y 46.54%
EPS Next 3Y 22.92% EPS Next 5Y N/A
Revenue growth 1Y 77.58% Revenue growth 3Y 4.32%
Revenue growth 5Y 9.59% Revenue growth Q2Q 89.01%
Revenue Next Year 45.26% Revenue Next 2Y 16.06%
Revenue Next 3Y 8.77% Revenue Next 5Y N/A
EBIT growth 1Y 202.32% EBIT growth 3Y 7.58%
EBIT growth 5Y 55.92% EBIT Next Year 158.7%
EBIT Next 3Y 30.6% EBIT Next 5Y N/A
FCF growth 1Y 350.74% FCF growth 3Y 33.46%
FCF growth 5Y 22.17% OCF growth 1Y 402.42%
OCF growth 3Y 13.37% OCF growth 5Y 26.64%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the EuroNext

Screen Image

Growth Stock Screener

Find more growth stocks the EuroNext

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the EuroNext

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the EuroNext

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the EuroNext